159 related articles for article (PubMed ID: 8314352)
1. Response of normal and oncogene-transformed human mammary epithelial cells to transforming growth factor beta 1 (TGF-beta 1): lack of growth-inhibitory effect on cells expressing the simian virus 40 large-T antigen.
Basolo F; Fiore L; Ciardiello F; Calvo S; Fontanini G; Conaldi PG; Toniolo A
Int J Cancer; 1994 Mar; 56(5):736-42. PubMed ID: 8314352
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
Serra R; Verderame MF; Isom HC
Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of epithelial membrane antigen expression by transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
Walker-Jones D; Valverius EM; Stampfer MR; Lippman ME; Dickson RB
Cancer Res; 1989 Nov; 49(22):6407-11. PubMed ID: 2680064
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells.
Valverius EM; Bates SE; Stampfer MR; Clark R; McCormick F; Salomon DS; Lippman ME; Dickson RB
Mol Endocrinol; 1989 Jan; 3(1):203-14. PubMed ID: 2783757
[TBL] [Abstract][Full Text] [Related]
6. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
Valverius EM; Walker-Jones D; Bates SE; Stampfer MR; Clark R; McCormick F; Dickson RB; Lippman ME
Cancer Res; 1989 Nov; 49(22):6269-74. PubMed ID: 2553252
[TBL] [Abstract][Full Text] [Related]
7. Regulation of surface-differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c-Ha-ras proto-oncogene.
Basolo F; Serra C; Ciardiello F; Fiore L; Russo J; Campani D; Dolei A; Squartini F; Toniolo A
Int J Cancer; 1992 Jun; 51(4):634-40. PubMed ID: 1601524
[TBL] [Abstract][Full Text] [Related]
8. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson RB; Bianco AR; Salomon DS
Mol Carcinog; 1992; 6(1):43-52. PubMed ID: 1354442
[TBL] [Abstract][Full Text] [Related]
10. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
[TBL] [Abstract][Full Text] [Related]
12. Effect of transforming growth factor beta on rat hepatocyte cell lines depends upon the state of tumorigenic progression.
Reeder MK; Isom HC
Cell Growth Differ; 1996 Apr; 7(4):449-60. PubMed ID: 9052986
[TBL] [Abstract][Full Text] [Related]
13. Defective interleukin six expression and responsiveness in human mammary cells transformed by an adeno 5/SV40 hybrid virus.
Basolo F; Fiore L; Calvo S; Falcone V; Conaldi PG; Fontanini G; Caligo AM; Merlo G; Gluzman Y; Toniolo A
Br J Cancer; 1996 Jun; 73(11):1356-61. PubMed ID: 8645579
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
15. Different signalling pathways involved in transforming growth factor-beta 1-induced morphological change and type IV collagen synthesis in simian virus-40-immortalized normal human salivary gland duct and myoepithelial cell clones.
Azuma M; Tamatani T; Fukui K; Yuki T; Motegi K; Sato M
Arch Oral Biol; 1996 May; 41(5):413-24. PubMed ID: 8809303
[TBL] [Abstract][Full Text] [Related]
16. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
Houck KA; Michalopoulos GK; Strom SC
Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
[TBL] [Abstract][Full Text] [Related]
17. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
Longstreet M; Miller B; Howe PH
Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
[TBL] [Abstract][Full Text] [Related]
18. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
19. Effects of TGF beta on normal and malignant mammary epithelium.
Zugmaier G; Lippman ME
Ann N Y Acad Sci; 1990; 593():272-5. PubMed ID: 2375597
[TBL] [Abstract][Full Text] [Related]
20. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
